Drug Shortage Report for ESOMEPRAZOLE
Report ID | 114022 |
Drug Identification Number | 02394839 |
Brand name | ESOMEPRAZOLE |
Common or Proper name | ESOMEPRAZOLE |
Company Name | PRO DOC LIMITEE |
Market Status | MARKETED |
Active Ingredient(s) | ESOMEPRAZOLE |
Strength(s) | 20MG |
Dosage form(s) | TABLET (DELAYED-RELEASE) |
Route of administration | ORAL ORAL |
Packaging size | 30 |
ATC code | A02BC |
ATC description | DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2020-05-04 |
Estimated end date | 2021-09-23 |
Actual end date | 2021-09-21 |
Shortage status | Resolved |
Updated date | 2021-09-22 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2925 BOULEVARD INDUSTRIEL LAVAL, QUEBEC CANADA H7L 3W9 |
Company contact information | 2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v26 | 2021-09-22 | English | Compare |
v25 | 2021-09-21 | French | Compare |
v24 | 2021-09-21 | English | Compare |
v23 | 2021-09-20 | French | Compare |
v22 | 2021-09-20 | English | Compare |
v21 | 2021-09-15 | French | Compare |
v20 | 2021-09-15 | English | Compare |
v19 | 2021-09-13 | French | Compare |
v18 | 2021-09-13 | English | Compare |
v17 | 2021-08-04 | French | Compare |
v16 | 2021-08-04 | English | Compare |
v15 | 2021-07-13 | French | Compare |
v14 | 2021-07-13 | English | Compare |
v13 | 2021-03-02 | French | Compare |
v12 | 2021-03-02 | English | Compare |
v11 | 2021-01-13 | French | Compare |
v10 | 2021-01-13 | English | Compare |
v9 | 2020-11-30 | French | Compare |
v8 | 2020-11-30 | English | Compare |
v7 | 2020-10-21 | French | Compare |